Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBAT-COVID: Iloprost for COVID-19 Respiratory Failure
NCT04420741Phase 2Completed
- Start
- Jun 2020
- Primary completion
- Feb 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of iloprost in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS). Started Jun 2020; status: completed.
02
Drugs
iloprost
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04420741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04420741.